Tag: contralateralBreastCancer
Articles
- BRCA1 and BRCA2 mutation carriers
- Latest research concerning breast cancer in old age
- Latest research concerning lobular breast cancer prognosis
- Lobular breast cancer and LCIS
News
- Alcohol consumption can reduce breast cancer survival
- Bilateral mastectomy can improve ER-/PR- breast cancer survival in some cases
- BRCA1 and BRCA2 carriers have increasing risks of breast and ovarian cancers into old age
- Breast cancer survivors at higher risk of new breast tumors and endometrial cancer
- Contralateral mastectomy in BRCA1/2 patients does not improve survival
- Lobular and ductal breast cancer can be treated similarly based on other important tumor characteristics
- Mastectomy of the other breast improves survival in some cases
- Obesity, smoking and alcohol increase risk of new ER+ tumor in the other breast
- Postmenopausal women diagnosed with breast cancer should have MRI of the other breast
- Pre-operative MRIs find additional disease in 20% of lobular breast cancer patients
- Screening mammograms are less accurate in breast cancer survivors
- Second breast cancer highly likely among women with ER- tumors and/or family history
- Some older women with early stage breast cancer do well without surgery
- Women with DCIS and dense breasts have a higher risk of additional breast cancer
Studies
- Accuracy and Outcomes of Screening Mammography in Women With a Personal History of Early-Stage Breast Cancer
- Adjuvant Hormonal Therapy for Breast Cancer and Risk of Hormone Receptor-Specific Subtypes of Contralateral Breast Cancer
- Adjuvant Hormonal Therapy for Breast Cancer and Risk of Hormone Receptor-Specific Subtypes of Contralateral Breast Cancer
- Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study
- Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status
- Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics
- Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer
- Body mass index and risk of second primary breast cancer: The WECARE Study
- Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer
- Concordance in histological and biological parameters between first and second primary breast cancers
- Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
- Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence
- Effect of the introduction of preoperative MRI scans for lobular cancer in an individual breast unit
- Improved Outcomes of Breast-Conserving Therapy for Patients with Ductal Carcinoma in Situ
- In Newly Diagnosed Breast Cancer, Screening MRI of the Contralateral Breast Detects Mammographically Occult Cancer, Even in Elderly Women: The Mayo Clinic in Florida Experience
- Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan
- Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy
- Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer
- Lobular Breast Cancer: Same Survival and Local Control Compared with Ductal Cancer, but Should Both Be Treated the Same Way? Analysis of an Institutional Database over a 10-Year Period
- Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy
- Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre
- Mammographic Density and Risk of Second Breast Cancer after Ductal Carcinoma In situ
- Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
- Patient and tumor characteristics associated with contralateral breast cancer in a nested population-based case-control study
- Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
- Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients
- Relationship between diabetes and risk of second primary contralateral breast cancer
- Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor-Positive Invasive Breast Cancer
- Reproductive Status at First Diagnosis Influences Risk of Radiation-Induced Second Primary Contralateral Breast Cancer in the WECARE Study
- Risk of Primary Non-Breast Cancer After Female Breast Cancer by Age at Diagnosis
- Risk of second breast cancer according to estrogen receptor status and family history
- Second malignancies after breast cancer: the impact of different treatment modalities
- Second Primary Breast Cancer Occurrence According to Hormone Receptor Status
- Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age
- Second primary tumors after breast cancer: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study
- Short-Term Biomarker Modulation Prevention Study of Anastrozole in Women at Increased Risk for Second Primary Breast Cancer
- The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty